Vaccine prevention of meningococcal disease, coming soon?

This publication has 92 references indexed in Scilit:

• Production and Characterization of a New Monoclonal Antibody AgainstNeisseria meningitidis: Study of the Cross-Reactivity with Different Bacterial Genera
  Hybridoma, 2000
• Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491
  Nature, 2000
• Assessment of Complement Deficiency in Patients with Meningococcal Disease in the Netherlands
  Clinical Infectious Diseases, 1999
• Preclinical Evaluation of a Novel Group B Meningococcal Conjugate Vaccine that Elicits Bactericidal Activity in both Mice and Nonhuman Primates
  The Journal of Infectious Diseases, 1997
• Assessment of the Direct Effectiveness of BC Meningococcal Vaccine in Rio de Janeiro, Brazil: A Case-Control Study
  International Journal of Epidemiology, 1995
• The antimeningococcal vaccine VAMENGOC B-C induced poor serum and salivary antibody response in young Brazilian children
  The Pediatric Infectious Disease Journal, 1995
• Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines
  The Journal of Pediatrics, 1992
• N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis.
  The Journal of Experimental Medicine, 1987
• AGE-SPECIFIC DIFFERENCES IN DURATION OF CLINICAL PROTECTION AFTER VACCINATION WITH MENINGOCOCCAL POLYSACCHARIDE A VACCINE
  The Lancet, 1985
• Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age
  New England Journal of Medicine, 1977